|
1
|
Ghosh AK, Bradham WS, Gleaves LA, De Taeye
B, Murphy SB, Covington JW and Vaughan DE: Genetic deficiency of
plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged
mice: Involvement of constitutive transforming growth factor-beta
signaling and endothelial-to-mesenchymal transition. Circulation.
122:1200–1209. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krieg T, Abraham D and Lafyatis R:
Fibrosis in connective tissue disease: The role of the
myofibroblast and fibroblast-epithelial cell interactions.
Arthritis Res Ther. 9(Suppl 2): S42007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kwak HB, Kim JH, Joshi K, Yeh A, Martinez
DA and Lawler JM: Exercise training reduces fibrosis and matrix
metalloproteinase dysregulation in the aging rat heart. FASEB J.
25:1106–1117. 2011. View Article : Google Scholar :
|
|
4
|
Yu XY, Qiao SB, Guan HS, Liu SW and Meng
XM: Effects of visfatin on proliferation and collagen synthesis in
rat cardiac fibroblasts. Horm Metab Res. 42:507–513. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rezzani R, Angoscini P, Rodella L and
Bianchi R: Alterations induced by cyclosporine A in myocardial
fibers and extracellular matrix in rat. Histol Histopathol.
17:761–766. 2002.PubMed/NCBI
|
|
6
|
Gao HC, Zhao H, Zhang WQ, Li YQ and Ren
LQ: The role of the Rho/Rock signaling pathway in the pathogenesis
of acute ischemic myocardial fibrosis in rat models. Exp Ther Med.
5:1123–1128. 2013.PubMed/NCBI
|
|
7
|
Díez J: Mechanisms of cardiac fibrosis in
hypertension. J Clin Hypertens (Greenwich). 9:546–550. 2007.
View Article : Google Scholar
|
|
8
|
Hinz B: Formation and function of the
myofibroblast during tissue repair. J Invest Dermatol. 127:526–537.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sato M, Shegogue D, Gore EA, Smith EA,
McDermott PJ and Trojanowska M: Role of p38 MAPK in transforming
growth factor beta stimulation of collagen production by
scleroderma and healt hy der ma l fibroblasts. J Invest Dermatol.
118:704–711. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bhattacharyya S, Wei J and Varga J:
Understanding fibrosis in systemic sclerosis: Shifting paradigms,
emerging opportunities. Nat Rev Rheumatol. 8:42–54. 2012.
View Article : Google Scholar
|
|
11
|
Huynh K, McMullen JR, Julius TL, Tan JW,
Love JE, Cemerlang N, Kiriazis H, Du XJ and Ritchie RH:
Cardiac-specifc IGF-1 receptor transgenic expression protects
against cardiac fibrosis and diastolic dysfunction in a mouse model
of diabetic cardiomyopathy. Diabetes. 59:1512–1520. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haleagrahara N, Chakravarthi S and Mathews
L: Insulin like growth factor-1 (IGF-1) causes overproduction of
IL-8, an angiogenic cytokine and stimulates neovascularization in
isoproterenol-induced myocardial infarction in rats. Int J Mol Sci.
12:8562–8574. 2011. View Article : Google Scholar
|
|
13
|
Yousefi K, Fathiazad F, Soraya H,
Rameshrad M, Maleki-Dizaji N and Garjani A: Marrubium vulgare L.
methanolic extract inhibits infammatory response and prevents
cardiomyocyte fibrosis in isoproterenol-induced acute myocardial
infarction in rats. Bioimpacts. 4:21–27. 2014.
|
|
14
|
Xiao X and Benjamin IJ: Stress-response
proteins in cardiovascular disease. Am J Hum Genet. 64:685–690.
1999. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Benjamin IJ and McMillan DR: Stress (heat
shock) proteins: Molecular chaperones in cardiovascular biology and
disease. Circ Res. 83:117–132. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kregel KC: Heat shock proteins: Modifying
factors in physiological stress responses and acquired
thermotolerance. J Appl Physiol 1985. 92:2177–2186. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bellaye PS, Burgy O, Causse S, Garrido C
and Bonniaud P: Heat shock proteins in fibrosis and wound healing:
Good or evil? Pharmacol Ther. 143:119–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park SJ, Sohn HY and Park SI: TRAIL
regulates collagen production through HSF1-dependent Hsp47
expression in activated hepatic stellate cells. Cell Signal.
25:1635–1643. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang Y and Zheng J: Roles of HSP47/HSF1 in
pulmonary fibrosis. Shandong Yi Yao. 50:117–118. 2010.In
Chinese.
|
|
21
|
Xiao H, Lv J, Chen Q, Liu R and Ling G:
Role of HSP47 in renal tubulointerstitial fibrosis induced by
transforming growth factor β1. Chin J Nephrol. 27:923–927. 2011.In
Chinese.
|
|
22
|
Deng J, Wang D, Zhang Y and Yuan F: The
expression of HSP47 in renal tissues of chronic renal disease
patients and its significance. Chongqing Yi Xue. 34:1029–1031.
2005.In Chinese.
|
|
23
|
Hai G, Li J, Jia Y, Xia W, Chen Y and Liu
J: The effect of TGF-β1 on the expression of HSP47 and collagen in
HFL cells. Guangdong Yi Xue. 34:2632–2634. 2013.In Chinese.
|
|
24
|
Li Y, Wu W, Jiang Y and Wang K: Effect of
heat shock protein 47 on the expression of collagen I induced by
TGF-beta(1) in hepatic stellate cell-T6 cells. Zhong Nan Da Xue Xue
Bao Yi Xue Ban. 32:650–655. 2007.In Chinese. PubMed/NCBI
|
|
25
|
Bradford MM: A rapid and sensitive method
for the quanititation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nagata K: Hsp47: A collagen-specific
molecular chaperone. Trends Biochem Sci. 21:22–26. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Siu PM, Wang Y and Alway SE: Apoptotic
signaling induced by H2O2-mediated oxidative stress in
differentiated C2C12 myotubes. Life Sci. 84:468–481. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong RQ, Wang ZF, Zhao C, Gu HR, Hu ZW,
Xie J and Wu YQ: Toll-like receptor 4 knockout protects against
isoproterenol-induced cardiac fibrosis: The role of autophagy. J
Cardiovasc Pharmacol Ther. 20:84–92. 2015. View Article : Google Scholar
|
|
29
|
Hribal ML, Procopio T, Petta S, Sciacqua
A, Grimaudo S, Pipitone RM, Perticone F and Sesti G: Insulin-like
growth factor-I, infam-matory proteins, and fibrosis in subjects
with nonalcoholic fatty liver disease. J Clin Endocrinol Metab.
98:E304–E308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roche P and Czubryt MP: Transcriptional
control of collagen I gene expression. Cardiovasc Hematol Disord
Drug Targets. 14:107–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ocaranza MP, Díaz-Araya G, Chiong M, Muñoz
D, Riveros JP, Ebensp erger R, Sabat S, Irarrázaval P, Jalil JE and
Lavandero S: Isoproterenol and angiotensin I-converting enzyme in
lung, left ventricle, and plasma during myocardial hypertrophy and
fbrosis. J Cardiovasc Pharmacol. 40:246–254. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takemoto Y, Yoshiyama M, Takeuchi K, Omura
T, Komatsu R, Izumi Y, Kim S and Yoshikawa J: Increased JNK, AP-1
and NF-kappa B DNA binding activities in isoproterenol-induced
cardiac remodeling. J Mol Cell Cardiol. 31:2017–2030. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gallego M, Espiña L, Vegas L, Echevarria
E, Iriarte MM and Casis O: Spironolactone and captopril attenuates
isopro-terenol-induced cardiac remodelling in rats. Pharmacol Res.
44:311–315. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Leenen FH, White R and Yuan B:
Isoproterenol-induced cardiac hypertrophy: Role of circulatory
versus cardiac renin-angiotensin system. Am J Physiol Heart Circ
Physiol. 281:H2410–H2416. 2001.PubMed/NCBI
|
|
35
|
Ciocca DR, Arrigo AP and Calderwood SK:
Heat shock proteins and heat shock factor 1 in carcinogenesis and
tumor development: an update. Arch Toxicol. 87:19–48. 2013.
View Article : Google Scholar
|
|
36
|
Vihervaara A and Sistonen L: HSF1 at a
glance. J Cell Sci. 127:261–266. 2014. View Article : Google Scholar : PubMed/NCBI
|
